AmirLermanMD

Cardiology • Rochester, MN

Professor, Internal Medicine, Mayo Medical School

Join to view full profile

Dr. Lerman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lerman's full profile

Already have an account?

Office
200 1st St Sw
Rochester, MN 55905
Phone+1 507-284-2511

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 1991 - 1994
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1987 - 1987
Maimonides Medical CenterResidency, Internal Medicine, 1986 - 1987
Technion-Israel Inst of Technology Faculty of MedicineClass of 1986

Certifications & Licensure

AZ State Medical License 2011 - 2026
MN State Medical License 1989 - 2025
American Board of Internal Medicine Internal Medicine
National Board of Physicians and Surgeons Cardiovascular Disease
National Board of Physicians and Surgeons Internal Medicine

Awards, Honors, & Recognition

Fellow (FACC) American College of Cardiology

Clinical Trials

Correlation of Endothelial Function and Early Coronary Artery Disease in Humans Start of enrollment: 2001 Jul 01
Completed
Phase 3
Effect of Chronic Statin and Viagra Therapy in Persons With Endothelial Cell Dysfunction Start of enrollment: 2004 Jun 01
Withdrawn
Not Applicable
The Acute Effect of Statins on Inflammatory Markers of Athersclerotic Tissue Start of enrollment: 2002 Sep 01
Completed
Not Applicable
Effect of Acute Statin Treatment in Patients Undergoing Percutaneous Coronary Intervention Start of enrollment: 2002 Nov 01
Terminated
Not Applicable
Comparison of Coronary CT With IVUS in Heart Transplant Population Start of enrollment: 2007 Nov 01
Withdrawn
Not Applicable
Effects of Cranberry Juice on Risk Factors for Cardiovascular Disease Start of enrollment: 2008 Feb 01
Completed
Effects of EGCG-Enhanced Extra Virgin Olive Oil on Endothelial Function Start of enrollment: 2008 Feb 01
Completed
The Effect of Tekturna on Endothelial Function and Endothelial Progenitor Cells in Patients With Early Atherosclerosis Start of enrollment: 2010 Feb 01
Terminated
Phase 3
Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Progenitor Cells and Coronary Atherosclerosis in Humans Start of enrollment: 2010 Feb 04
Completed
Phase 3
Prediction of Cardiovascular Events in Vulnerable Patients Following Acute Coronary Syndrome Start of enrollment: 2011 Sep 01
Completed
Not Applicable
Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography Start of enrollment: 2011 Aug 01
Completed
Lp-PLA2 and Coronary Atherosclerosis in Humans Start of enrollment: 2009 Feb 01
Completed
Not Applicable
Assessment of Coronary Plaque Composition Start of enrollment: 2010 Jan 01
Completed
Phase 1
Association of Endothelial Function and Clinical Outcomes in Subjects Admitted to Chest Pain Unit Start of enrollment: 2012 Oct 01
Active, not recruiting
Olive Oil and Cardiovascular Health Start of enrollment: 2013 Aug 01
Withdrawn
Not Applicable
Is Our Microbiome a Predictor of Cardiac Risk Start of enrollment: 2013 Nov 01
Recruiting
Effects of Chardonnay Seed Flour on Vascular Health Start of enrollment: 2014 Mar 01
Completed
Not Applicable
Study of Intracoronary CD34+ Cell Administration in Patients With Early Coronary Atherosclerosis Start of enrollment: 2018 Jun 15
Completed
Phase 1
Feasibility and Efficacy of Coronary Sinus Narrowing in Patients With Coronary Microvascular Dysfunction Start of enrollment: 2021 Jun 28
Completed
Not Applicable
A Study of Sleep Patterns to Determine Predictive Markers Due to Cardiovascular Disease in Elderly Patients Start of enrollment: 2023 May 23
Terminated
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

1284 citations
Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): A mimic of acute myocardial infarction
Abhiram Prasad, Amir Lerman, Charanjit S. Rihal
American Heart Journal. 2008-03-01
476 citations
International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management
Jelena-Rima Ghadri, Ilan S. Wittstein, Abhiram Prasad, Scott W. Sharkey, Keigo Dote
European Heart Journal. 2018-06-07
235 citations
5-fluorouracil and cardiotoxicity: a review
Jaskanwal D. Sara, Jasvinder Kaur, Ryan Khodadadi, Muneeb Rehman, Ronstan Lobo
Therapeutic Advances in Medical Oncology. 2018-06-18

Journal Articles

Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention
Naveen L Pereira, Verghese Mathew, Charles Cagin, Amir Lerman, Charanjit Rihal, JAMA
Focus on Coronary Physiology Assessment in Special Cohorts Editorial Comment Coronary Microvasculature: Are the Small and the Mighty Cross-Talking with the Epicardial ...
Amir Lerman, Michel T Corban, Lilach O Lerman, ScienceDirect

Lectures

Audience ARS Question
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Dissecting the Data: Update on Spontaneous Coronary Artery Dissection
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
Acute Coronary Syndromes in Patients with Active Hematologic Malignancies – Incidence, Management, and Outcomes
Scientific Sessions 2007, Orlando, Florida, USA
Local Low Shear Stress and Endothelial Dysfunction in Patients with Nonobstructive Coronary Atherosclerosis
American Heart Association, Scientific Sessions 2007, Orlando, Florida, USA
Join now to see all

Authored Content

Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary InterventionAugust 2020
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary InterventionAugust 2020
Acute Coronary Syndromes in Patients with Active Hematologic Malignancies – Incidence, Management, and OutcomesOctober 2018
Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
Chronic Inhibition of Lipoprotein-Associated Phospholipase A2 Does Not Improve Coronary Endothelial Function: A Prospective, Randomized-Controlled Trial☆January 2018
Join now to see all

Press Mentions

Hourglass-Shaped Stent Might Ease Tough-to-Treat AnginaNovember 11th, 2024
New Hourglass-Shaped Stent Offers Relief for Microvascular Chest PainNovember 7th, 2024
WizeCare Announces Know-How and Research Agreement with Mayo ClinicSeptember 7th, 2022
Join now to see all